EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological malignancies, is presenting clinical data from a ...

Emmy-winning 'Today' show weatherman Al Roker will be in Des Moines this weekend to serve as the keynote speaker for the 2025 ...

The TP53 gene or its proteins are also referred to as tumor protein TP53, cellular tumor antigen TP53, phosphoprotein TP53, antigen NY-CO-13, or transformation-related protein 53. Learn more below ...

The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

The Swedish biotech hopes its precision therapy will help patients with advanced solid tumors who currently have few ...

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

Actor Colin Egglesfield revealed this week that he was diagnosed with prostate cancer and underwent surgery, saying it was caught early. He has been diagnosed with testicular cancer twice before.

10, 2025 — A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with ...